Victoria Johnson

An audio recap of the top 5 stories in healthcare news from the week of 10/12-18.

Experts discuss how innovative treatments are revolutionizing atopic dermatitis care for children.

Tezepelumab is the first TSLP-targeting biologic to be approved for chronic rhinosinusitis with nasal poylps.

Experts explore the evolution of asthma and COPD treatments with targeted biologic therapies.

The therapy is currently approved in almost 50 countries under the name Trimbow.

A recent study reveals that hypertonic saline and carbocisteine do not effectively reduce pulmonary exacerbations.

New long-term data reveals that Papzimeos offers sustained relief for adults with recurrent respiratory papillomatosis, reducing the need for surgeries.

An audio recap of the top 5 stories in healthcare news from the week of 10/5-10/11.

The therapy was well-tolerated in the phase 2a ENV-IPF-101 trial, with mostly mild-to-moderate TEAEs related to treatment.

The new therapy, marketed as Jascayd, previously demonstrated safety and efficacy in the phase 3 FIBRONEER-IPF trial.

INO-3107 immunotherapy significantly reduces surgeries for recurrent respiratory papillomatosis.

An audio recap of the top 5 stories in healthcare news from the week of 9/28-10/04.

Q3 2025 saw more research emerge in asthma therapeutics and management as well as rarer pulmonary diseases.

September 2025 saw 1 new approval, new long term data on smoking and emphysema, and more.

Less than optimal outcomes with ASCVD also increased healthcare resource utilization and costs.

New research supports fimasartan, atorvastatin, and ezetimibe combination to blood pressure and cholesterol levels.

Cytisinicline shows promise as a safe and effective smoking cessation treatment, significantly improving quit rates in COPD.

AstraZeneca's Airsupra gains FDA approval for mild asthma, expanding its current label.

The EXHALE-4 study evaluating the oral small molecule has met its primary endpoint of improving pre-BD FEV1.

Avapritinib shows significant long-term benefits for indolent systemic mastocytosis while maintaining a favorable safety profile.

An audio recap of the top 5 stories in healthcare news from the week of 9/5-9/13.

Red light photodynamic therapy with 10% ALA gel shows superior clearance rates compared to vehicle treatment.

Baseline emphysema detected in low-dose CT scans predicts long-term mortality in asymptomatic adults.

Regeneron's innovative antibody therapies show promising results in alleviating cat and birch allergies.

Intralesional triamcinolone showed significantly greater hair regrowth and patient satisfaction.

An audio recap of the top 5 stories in healthcare news from the week of 08/31-9/5.

A study links paternal prepubertal passive smoke exposure to impaired lung function in offspring.

August 2025 saw a number of novel approvals and expert perspectives for World Lung Cancer Day.

Agios announces a 3-month extension for mitapivat's FDA review.